Alert: Major Price Advance (12/14/23)-Marker Therapeutics Inc (NASDAQ: MRKR).


Marker Therapeutics Inc (NASDAQ: MRKR) stock enjoyed a major increase of 11.4% on 12/14/23. The shares closed at $5.07. Moreover, this advance was accompanied by exceptionally high trading volume at 326% of normal. The stock has risen 76.7% during the last week and has been exceptionally strong relative to the market over the last nine months.


Current PriceTarget Research Rating

With future capital returns forecasted to be below the cost of capital, MRKR is expected to continue to be a modest Value Eraser.

Marker Therapeutics has a current Value Trend Rating of C (Neutral). The Value Trend Rating reflects very contradictory signals from PTR’s two proprietary measures of a stock’s attractiveness. Marker Therapeutics has a very low Appreciation Score of 14 but a very high Power Rating of 94, and the Neutral Value Trend Rating results.

Rating Review

In light of this very positive price change we are reviewing our current Overall Rating of C. This review will be completed in the next several days.

Be the first to comment

Leave a Reply

Your email address will not be published.